Laparoscopic Sleeve Gastrectomy: a Cohort Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

138 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-07-10

Study Completion Date

2020-04-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective cohort study, which subjects were obese patients requiring LSG surgery. LSG with different gastric resection starting points (2-4cm/4-6 cm from pylorus) as intervention method. The main observation is the incidence and extent of upper gastrointestinal symptoms (such as nausea, vomiting, retching, reflux, difficulty swallowing, etc.).In addition, secondary observations include the excess weight loss (%EWL) and postoperative complications. Aim to investigate the effects of LSG surgery in different starting points of gastric resection on postoperative upper gastrointestinal symptoms.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Gastric Volumetry by Gastric Tomodensitometry With Gas

NCT01963637

Morbid Obesity

COMPLETED NA

Effect of Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass on Gastroesophageal Reflux Disease: An 8-Year Prospective Cohort Study

NCT03692455

Gastroesophageal Reflux Disease Morbid Obesity

ENROLLING_BY_INVITATION

Endoscopic Sleeve Gastroplasty for Morbid Obesity

NCT03124485

Endoscopic Sleeve Gastroplasty

UNKNOWN NA

A 3-Arm Study Comparing the Efficacy of Anti-Reflux Reconstruction Protocols After Laparoscopic Proximal Gastrectomy

NCT06347757

Anti-Reflux Alimentary Reconstruction Laparoscopic Proximal Gastrectomy Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction

COMPLETED NA

Sleeve Gastrectomy With Reestablishment of the Acute Angle of His (SG-REACH) in Obese Patients

NCT05452980

Gastroesophageal Reflux Disease Excessive Weight Loss Total Weight Loss +2 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laparoscopic Sleeve Gastrectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group1: 4-6cm

4-6cm from starting point of gastrectomy to pylorus

Intervention Type PROCEDURE

The starting point of gastrectomy of the distance from the pylorus is 4-6cm during operative.

Group2: 2-4cm

2-4cm from starting point of gastrectomy to pylorus

Intervention Type PROCEDURE

The starting point of gastrectomy of the distance from the pylorus is 2-4cm during operative.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

4-6cm from starting point of gastrectomy to pylorus

The starting point of gastrectomy of the distance from the pylorus is 4-6cm during operative.

Intervention Type PROCEDURE

2-4cm from starting point of gastrectomy to pylorus

The starting point of gastrectomy of the distance from the pylorus is 2-4cm during operative.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients were accepted for surgery if they satisfied the guidelines of the Society of Chinese Gastroenterological Surgeons \[body mass index (BMI) ≥40 kg/m2 or BMI ≥35 kg/m2 with at least one co-morbidity associated with obesity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea), age between 18 and 60 years, and failure of conservative treatment over 2 years\].
* All patients undergo preoperative upper gastrointestinal (GI) endoscopy.

Exclusion Criteria

* any patient who had previously been submitted to any type of bariatric surgery;
* patient currently taking anti-nausea or GERD medications preoperatively;
* any current smokers；
* active duodenal/gastric ulcer disease；
* difficult to treat gastroesophageal reflux disease (GERD) with a large hiatal hernia；
* previous major gastrointestinal surgery；
* diagnosed or suspected malignancy；
* poorly controlled significant medical or psychiatric disorders；
* disorders such as a medical history of major pathology;
* can not be able to understand and willing to participate in this registry with signature.

Minimum Eligible Age

15 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No